The Regulatory Situation After the Trump Executive Orders Regulatory Freeze Pending Review
Additional Compensation from the Government: A Brief Comparison of REAs and Claims
DE Under 3: EEOC Quietly Denys FOIA Requests, Pay Data Study Results & OFCCP Clears Up AAP Portal “Deadline” Confusion
DE Under 3: Secretary Walsh Intervenes in Court, Religious Exemption Updates, & AAP Verification Deadline Extension Developments
DE Under 3: USDOJ’s Settlement Affecting Recruiters, OFCCP’s AAP Verification Deadline Extension & SCOTUS’ New Ruling
PODCAST: Williams Mullen's Benefits Companion - Health Plan Transparency Requirements
The Critical Nature of Bankruptcy Dates and Deadlines
Government Contractors: Preparing for OFCCP’s Affirmative Action Program Compliance Certification
COBRA Deadlines and Proofs of Mailing in Carter v. Southwest Airlines Co. Board of Trustees
#WorkforceWednesday: DOL Electronic Notices Guidance, EEO-1 Reporting Delayed, CA COVID-19 Paid Sick Leave - Employment Law This Week®
Information Blocking: How Will the New Rule Impact the Health Care Industry?
COVID-19 Impact for Health & Welfare Plans (Troutman Sanders and Pepper Hamilton COVID-19 Issues for Employers Podcast Series)
Underwriters, Universities and Government Debt Issuers Face a Critical Deadline
Obamacare Provision Requiring Businesses to Provide Health Insurance Delayed Until 2015
Former SEC Chairman David Ruder Discusses the Dodd-Frank Timeline, Volcker Rule & Cost Benefit Rules (Part 2 of 2)
Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes and more recently for obesity and other labeled and off-label indications for...more
Deadlines are upcoming related to the multi-district per- and polyfluoroalkyl substances (PFAS) litigation. The relevant settlements are with DuPont, Chemours, and Corteva (collectively, DuPont) and 3M, parties who allegedly...more
FDA Warning letters can be harbinger of formal civil and criminal investigations. If your business receives such a notice of non-compliance from the FDA, you should immediately contact an experienced FDA defense attorney....more